Bristol-Myers Squibb's third-quarter results exceeded expectations, raising revenue expectations for 2026, and the pre-market stock price rose 2.2%.

Zhitongcaijing · 2d ago
Bristol-Myers Squibb's third-quarter results exceeded expectations, raising revenue expectations for 2026, and the pre-market stock price rose 2.2%.